glp 1 agonist stands for GLP-1 Medications Infographic Glucagon-like peptide 1 (GLP-1) -

They differ in potency, duration of action, and specific receptor binding characteristics, but theyre fundamentally doing the same thing: mimicking and amplifying your bodys natural GLP-1 signals

One of these chemicals was eventually identified as GLP-1

[1,3,5] Diabetic retinopathy Rapid improvements in glucose control have been associated with a temporary worsening of diabetic retinopathy

The risk-benefit profile of triple agonists remains under investigation

As demand outpaces supply, shortages have been reported, particularly in Europe, where the European Medicines Agency (EMA) does not anticipate resolution until beyond 2024

The dual use of the same medications for diabetes and weight loss introduces operational complexity that did not exist when these drugs were confined to a single indication